Several CVOTs have demonstrated that GLP-1 RAs reduced CV risk in T2DM patients with established ASCVD or high CV risk independent of HbA1c levels
The authors said they examined gastrointestinal adverse events associated with GLP-1 agonists used for weight loss in a clinical setting because randomized trials evaluating their efficacy were not designed to capture these events due to small sample sizes and short follow-up. For their study, researchers used a random sample of 16 million patients taken between 2006 and 2020 from the PharMetrics Plus, a health claims database with 93% of all U.S
Among the respondents who report patients asking about third-party telehealth prescribing, almost two-thirds (64%) actively advise patients against it
The health consequences of poor sleep are serious enough that all treatments should be discussed with a Midi clinician or a specialist with a thorough understanding of what women experience at midlife
In March, the company announced a strategic pivot to move away from cheaper compounded GLP-1 drugs to expand its assortment of branded drugs
50,51 As expected, cinchonine dose-dependently reduced body weight gain in ob/ob-GAN NASH mice, which was consistent with decreased food intake
